Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Genius Sports Limited (NYSE: GENI) closed at $10.63 in the last session, down -4.06% from day before closing price of $11.08. In other words, the price has decreased by -$4.06 from its previous closing price. On the day, 2.09 million shares were traded. GENI stock price reached its highest trading level at $11.12 during the session, while it also had its lowest trading level at $10.55.
Ratios:
We take a closer look at GENI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.97. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 18, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Stevens Eric bought 79,373 shares for $9.38 per share.
Davison Jack bought 100,388 shares of GENI for $876,939 on Jan 17 ’25. On Jan 10 ’25, another insider, Davison Jack, who serves as the Officer of the company, bought 8,202 shares for $8.73 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2579093248 and an Enterprise Value of 2126215936. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.37 while its Price-to-Book (P/B) ratio in mrq is 3.92. Its current Enterprise Value per Revenue stands at 4.162 whereas that against EBITDA is -82.994.
Stock Price History:
The Beta on a monthly basis for GENI is 2.02, which has changed by 0.96106195 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $11.16, while it has fallen to a 52-week low of $4.91. The 50-Day Moving Average of the stock is 14.56%, while the 200-Day Moving Average is calculated to be 34.23%.
Shares Statistics:
According to the various share statistics, GENI traded on average about 3.07M shares per day over the past 3-months and 5085200 shares per day over the past 10 days. A total of 239.82M shares are outstanding, with a floating share count of 216.07M. Insiders hold about 9.90% of the company’s shares, while institutions hold 76.61% stake in the company. Shares short for GENI as of 1741910400 were 31448933 with a Short Ratio of 10.26, compared to 1739491200 on 29193808. Therefore, it implies a Short% of Shares Outstanding of 31448933 and a Short% of Float of 14.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
